- Home
- SUGP vs BCLI Comparison
SUGP vs BCLI Comparison
Compare SUGP & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUGP
- BCLI
- Stock Information
- Founded
- SUGP 1998
- BCLI 2000
- Country
- SUGP Hong Kong
- BCLI United States
- Employees
- SUGP N/A
- BCLI N/A
- Industry
- SUGP
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SUGP
- BCLI Health Care
- Exchange
- SUGP NYSE
- BCLI Nasdaq
- Market Cap
- SUGP 9.6M
- BCLI 9.8M
- IPO Year
- SUGP 2024
- BCLI N/A
- Fundamental
- Price
- SUGP $0.50
- BCLI $1.08
- Analyst Decision
- SUGP
- BCLI Strong Buy
- Analyst Count
- SUGP 0
- BCLI 1
- Target Price
- SUGP N/A
- BCLI $30.00
- AVG Volume (30 Days)
- SUGP 146.6K
- BCLI 473.4K
- Earning Date
- SUGP 07-21-2025
- BCLI 08-13-2025
- Dividend Yield
- SUGP N/A
- BCLI N/A
- EPS Growth
- SUGP 1.19
- BCLI N/A
- EPS
- SUGP 0.11
- BCLI N/A
- Revenue
- SUGP $23,446,259.00
- BCLI N/A
- Revenue This Year
- SUGP N/A
- BCLI N/A
- Revenue Next Year
- SUGP N/A
- BCLI N/A
- P/E Ratio
- SUGP $4.70
- BCLI N/A
- Revenue Growth
- SUGP 11.29
- BCLI N/A
- 52 Week Low
- SUGP $0.35
- BCLI $0.72
- 52 Week High
- SUGP $3.25
- BCLI $6.45
- Technical
- Relative Strength Index (RSI)
- SUGP 34.00
- BCLI 43.20
- Support Level
- SUGP $0.47
- BCLI $1.08
- Resistance Level
- SUGP $0.66
- BCLI $1.32
- Average True Range (ATR)
- SUGP 0.08
- BCLI 0.10
- MACD
- SUGP -0.02
- BCLI -0.01
- Stochastic Oscillator
- SUGP 30.36
- BCLI 4.00
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment. Geographically operates in Hong Kong, and Other foreign countries, with maximum revenue from Kong Kong.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.